Please visit our COVID-19 Resources page for more information on stroke care during the coronavirus pandemic. 
Nikunj Satani, MD, MPH

Nikunj Satani, MD, MPH

Assistant Professor

Dr. Satani finished his medical degree in 2008 and obtained his Masters in Public Health from the University of Texas Health Science Center (UTHealth) at Houston in 2013. He completed his postdoctoral training at the Institute for stroke and cerebrovascular diseases in 2019 and currently works as an Assistant Professor in the Department of Neurology at UTHealth. He has over 10 years of basic science, clinical and translational research in the field of neurology.

Dr. Satani has expertise in cellular therapy, neuroimmunology and drug discovery. He has a US patent on the novel small molecule inhibitors and his peer-reviewed publications feature in top-tier journals such as Nature, Nature Chemical Biology, Nature Communications, and Cancer Cell. His current areas of research revolve around understanding the molecular mechanisms involved in ischemic stroke after cellular therapy.

Publications

https://www.ncbi.nlm.nih.gov/pubmed/?term=Nikunj+Satani

Education & Training

Medical Degree 

Smt. N.H.L. Municipal Medical College - Ahmedabad, Gujarat, India,

Masters of Public Health

University of Texas Health Science Center at Houston, School of Public Health - Houston, Texas

Dr. Satani’s current areas of research revolve around understanding the molecular mechanisms involved in ischemic stroke after cellular therapy. He is keen on exploring and understanding the contributions of peripheral organs in brain recovery after stroke.

Clinical Interests:

  • Ischemic Stroke
  • Vascular Dementia

Research Interests:

  • Cellular therapy in ischemic stroke
  • Molecular mechanisms mediating Lung-Brain and Spleen-Brain crosstalk after stroke

Additional Information:

Google Scholar Citations Profile: https://scholar.google.com/citations?user=sSa7bNMAAAAJ&hl=en 

PubMed URL: https://pubmed.ncbi.nlm.nih.gov/?term=Nikunj+Satani